diet shot semaglutide Weight-loss drug called Wegovy receives FDA approval WeightLoss | Get Slims

Fernndez-Ruiz I (2023)

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

In May 2025, Illumina, Inc., and Ovation.io, Inc., announced the development of the largest commercially available clinical multiomic dataset from 25,000 patients treated with glucagon-like peptide-1 (GLP-1) receptor agonist therapies

Research Applications GH Axis Research: Comprehensive dual-pathway growth hormone secretion studies

Over another four weeks, the dose might go up to 1.0 mg, continuing the gradual dose escalation

Patients taking medications that affect heart rate, particularly beta-blockers, calcium channel blockers, or antiarrhythmic drugs, should be identified, as these may modify the heart rate response to GLP-1 therapy